nach oben

04.05.2024 | Review

Impact of Sex in the Incidence of Heart Failure in Patients with Chronic Coronary Syndrome

verfasst von: Ramón López-Palop, Pilar Carrillo, Íñigo Lozano

Erschienen in: Current Heart Failure Reports

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

This review examines the available evidence concerning the incidence of heart failure in patients with chronic coronary syndrome, with a focus on gender differences.

Recent Findings

The incidence of heart failure in the context of chronic coronary syndrome presents conflicting data. Most of the available information stems from studies involving stable patients’ post-acute coronary syndrome, revealing a wide range of incidence rates, from less than 3% to over 20%, observed over 5 years of follow-up. Regarding the gender differences in heart failure incidence, there is no consensus about whether women exhibit a higher incidence, particularly in the presence of evidence of obstructive coronary artery disease. However, in cases where obstructive coronary artery disease is absent, women may face a more unfavourable prognosis due to a higher prevalence of microvascular disease and heart failure with preserved ventricular function.

Summary

The different profile of ischaemic heart disease in women difficult to establish differences in prognosis independently associated with female sex. Targeted investigations are essential to discern the incidence of heart failure in chronic coronary syndrome and explore potential gender-specific associations.

Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020;41(3):407–77. https://doi.org/10.1093/eurheartj/ehz425.CrossRefPubMed

Virani SS, Newby LK, Arnold SV, Bittner V, Brewer LC, Demeter SH, et al. 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2023;82(9):833–955. https://doi.org/10.1016/j.jacc.2023.04.003.CrossRefPubMed

Boden WE, Marzilli M, Crea F, Mancini GBJ, Weintraub WS, Taqueti VR, et al. Evolving Management Paradigm for Stable Ischemic Heart Disease Patients: JACC Review Topic of the Week. J Am Coll Cardiol. 2023;81(5):505–14. https://doi.org/10.1016/j.jacc.2022.08.814.CrossRefPubMedPubMedCentral

Boden WE, Kaski JC, Berry C. Reprising Heberden’s description of angina pectoris after 250 years. Eur Heart J. 2023;44(19):1684–6. https://doi.org/10.1093/eurheartj/ehac643.CrossRefPubMed

Sinha A, Dutta U, Demir OM, De Silva K, Ellis H, Belford S, et al. Rethinking False Positive Exercise Electrocardiographic Stress Tests by Assessing Coronary Microvascular Function. J Am Coll Cardiol. 2024;83(2):291–9. https://doi.org/10.1016/j.jacc.2023.10.034.CrossRefPubMedPubMedCentral

McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2021;42(36):3599–726. https://doi.org/10.1093/eurheartj/ehab368.CrossRefPubMed

Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A, et al. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J. 2023;44(38):3720–826. https://doi.org/10.1093/eurheartj/ehad191.CrossRefPubMed

Almeida AG. MINOCA and INOCA: Role in Heart Failure. Curr Heart Fail Rep. 2023;20(3):139–50. https://doi.org/10.1007/s11897-023-00605-1.CrossRefPubMedPubMedCentral

Fritz J, Belovari K, Ulmer H, Zaruba MM, Messner M, Ungericht M, et al. Aetiology, ejection fraction and mortality in chronic heart failure: a mediation analysis. Heart. 2024;110(4):290–8. https://doi.org/10.1136/heartjnl-2023-322803.CrossRefPubMed

10.

Vicent L, Guerra J, Vazquez-Garcia R, Gonzalez-Juanatey JR, Dolz LM, Segovia J, et al. Ischemic Etiology and Prognosis in Men and Women with Acute Heart Failure. J Clin Med. 2021;10(8). https://doi.org/10.3390/jcm10081713

11.

Lewis EF, Moye LA, Rouleau JL, Sacks FM, Arnold JM, Warnica JW, et al. Predictors of late development of heart failure in stable survivors of myocardial infarction: the CARE study. J Am Coll Cardiol. 2003;42(8):1446–53. https://doi.org/10.1016/s0735-1097(03)01057-x.CrossRefPubMed

12.

Lewis EF, Solomon SD, Jablonski KA, Rice MM, Clemenza F, Hsia J, et al. Predictors of heart failure in patients with stable coronary artery disease: a PEACE study. Circ Heart Fail. 2009;2(3):209–16. https://doi.org/10.1161/CIRCHEARTFAILURE.108.820696.CrossRefPubMedPubMedCentral

13.

Lamblin N, Meurice T, Tricot O, de Groote P, Lemesle G, Bauters C. First Hospitalization for Heart Failure in Outpatients With Stable Coronary Artery Disease: Determinants, Role of Incident Myocardial Infarction, and Prognosis. J Card Fail. 2018;24(12):815–22. https://doi.org/10.1016/j.cardfail.2018.09.013.CrossRefPubMed

14.

Akashi N, Matoba T, Kohro T, Oba Y, Kabutoya T, Imai Y, et al. Sex Differences in Long-Term Outcomes in Patients With Chronic Coronary Syndrome After Percutaneous Coronary Intervention - Insights From a Japanese Real-World Database Using a Storage System. Circ J. 2023;87(6):775–82. https://doi.org/10.1253/circj.CJ-22-0653.CrossRefPubMed

15.

Parma Z, Jasilek A, Greenlaw N, Ferrari R, Ford I, Fox K, et al. Incident heart failure in outpatients with chronic coronary syndrome: results from the international prospective CLARIFY registry. Eur J Heart Fail. 2020;22(5):804–12. https://doi.org/10.1002/ejhf.1827.CrossRefPubMed

16.

Daly C, Clemens F, Lopez Sendon JL, Tavazzi L, Boersma E, Danchin N, et al. Gender differences in the management and clinical outcome of stable angina. Circulation. 2006;113(4):490–8. https://doi.org/10.1161/CIRCULATIONAHA.105.561647.CrossRefPubMed

17.

Sutton GC, Erik Otterstad J, Kirwan BA, Voko Z, de Brouwer S, Lubsen J, et al. The development of heart failure in patients with stable angina pectoris. Eur J Heart Fail. 2007;9(3):234–42. https://doi.org/10.1016/j.ejheart.2006.09.002.CrossRefPubMed

18.

Maron DJ, Hochman JS, Reynolds HR, Bangalore S, O’Brien SM, Boden WE, et al. Initial Invasive or Conservative Strategy for Stable Coronary Disease. N Engl J Med. 2020;382:1395–407. https://doi.org/10.1056/NEJMoa1915922.CrossRefPubMedPubMedCentral

19.

Boden WE, O’Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356(15):1503–16.CrossRefPubMed

20.

Bangalore S, Maron DJ, Stone GW, Hochman JS. Routine Revascularization versus Initial Medical Therapy for Stable Ischemic Heart Disease: A Systematic Review and Meta-Analysis of Randomized Trials. Circulation. 2020;0(0). https://doi.org/10.1161/CIRCULATIONAHA.120.048194

21.

Izadnegahdar M, Mackay M, Lee MK, Sedlak TL, Gao M, Bairey Merz CN, Humphries KH. Sex and Ethnic Differences in Outcomes of Acute Coronary Syndrome and Stable Angina Patients With Obstructive Coronary Artery Disease. Circ Cardiovasc Qual Outcomes. 2016;9(2 Suppl 1):S26-35. https://doi.org/10.1161/CIRCOUTCOMES.115.002483.CrossRefPubMed

22.

• Acharjee S, Teo KK, Jacobs AK, Hartigan PM, Barn K, Gosselin G, et al. Optimal medical therapy with or without percutaneous coronary intervention in women with stable coronary disease: A pre-specified subset analysis of the Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation (COURAGE) trial. Am Heart J. 2016;173:108-17. https://doi.org/10.1016/j.ahj.2015.07.020. Sub-study of the COURAGE clinical trial revealing a poorer prognosis solely in women managed conservatively. Results suggest potential benefits of percutaneous revascularization in women with stable coronary artery disease.

23.

Oliveira Guimaraes P, Granger CB, Stebbins A, Chiswell K, Held C, Hochman JS, et al. Sex Differences in Clinical Characteristics, Psychosocial Factors, and Outcomes Among Patients With Stable Coronary Heart Disease: Insights from the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial. J Am Heart Assoc. 2017;6(9). https://doi.org/10.1161/JAHA.117.006695

24.

Ezekowitz JA, Savu A, Welsh RC, McAlister FA, Goodman SG, Kaul P. Is There a Sex Gap in Surviving an Acute Coronary Syndrome or Subsequent Development of Heart Failure? Circulation. 2020;142(23):2231–9. https://doi.org/10.1161/CIRCULATIONAHA.120.048015.CrossRefPubMed

25.

Nuñez J, Lorenzo M, Minana G, Palau P, Monmeneu JV, Lopez-Lereu MP, et al. Sex differences on new-onset heart failure in patients with known or suspected coronary artery disease. Eur J Prev Cardiol. 2021;28(15):1711–9. https://doi.org/10.1093/eurjpc/zwab078.CrossRefPubMed

26.

Tsao CW, Aday AW, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, et al. Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association. Circulation. 2023;147(8):e93–621. https://doi.org/10.1161/CIR.0000000000001123.CrossRefPubMed

27.

Aggarwal NR, Patel HN, Mehta LS, Sanghani RM, Lundberg GP, Lewis SJ, et al. Sex Differences in Ischemic Heart Disease: Advances, Obstacles, and Next Steps. Circ Cardiovasc Qual Outcomes. 2018;11(2):e004437. https://doi.org/10.1161/CIRCOUTCOMES.117.004437.CrossRefPubMed

28.

Lawless M, Appelman Y, Beltrame JF, Navarese EP, Ratcovich H, Wilkinson C, Kunadian V. Sex differences in treatment and outcomes amongst myocardial infarction patients presenting with and without obstructive coronary arteries: a prospective multicentre study Eur Heart J Open. 2023; 3(2):oead033. https://doi.org/10.1093/ehjopen/oead033

29.

Hall M, Smith L, Wu J, Hayward C, Batty JA, Lambert PC, et al. Health outcomes after myocardial infarction: A population study of 56 million people in England. PLoS Med. 2024;21(2):e1004343. https://doi.org/10.1371/journal.pmed.1004343.CrossRefPubMedPubMedCentral

30.

Reynolds HR, Cyr DD, Merz CNB, Shaw LJ, Chaitman BR, Boden WE, et al. Sex Differences in Revascularization, Treatment Goals, and Outcomes of Patients With Chronic Coronary Disease: Insights From the ISCHEMIA Trial. J Am Heart Assoc. 2024;13(5):e029850. https://doi.org/10.1161/JAHA.122.029850.CrossRefPubMedPubMedCentral

31.

•• Elia E, Bruno F, Crimi G, Wanha W, Leonardi S, Mauro M, et al. Gender differences in the development of heart failure after acute coronary syndrome: Insight from the CORALYS registry. Int J Cardiol. 2024;397: 131622. https://doi.org/10.1016/j.ijcard.2023.131622. Study involving a substantial cohort of patients managed according to contemporary criteria, comparing outcomes between genders. Notable conclusions highlight equivalent long-term mortality despite variances in other events (including congestive heart failure).CrossRefPubMed

32.

Lindahl B, Baron T, Erlinge D, Hadziosmanovic N, Nordenskjold A, Gard A, Jernberg T. Medical Therapy for Secondary Prevention and Long-Term Outcome in Patients With Myocardial Infarction With Nonobstructive Coronary Artery Disease. Circulation. 2017;135(16):1481–9. https://doi.org/10.1161/CIRCULATIONAHA.116.026336.CrossRefPubMed

33.

Eggers KM, Hjort M, Baron T, Jernberg T, Nordenskjold AM, Tornvall P, Lindahl B. Morbidity and cause-specific mortality in first-time myocardial infarction with nonobstructive coronary arteries. J Intern Med. 2019;285(4):419–28. https://doi.org/10.1111/joim.12857.CrossRefPubMed

34.

Dreyer RP, Tavella R, Curtis JP, Wang Y, Pauspathy S, Messenger J, et al. Myocardial infarction with non-obstructive coronary arteries as compared with myocardial infarction and obstructive coronary disease: outcomes in a Medicare population. Eur Heart J. 2020;41(7):870–8. https://doi.org/10.1093/eurheartj/ehz403.CrossRefPubMed

35.

Canton L, Fedele D, Bergamaschi L, Foa A, Di Iuorio O, Tattilo FP, et al. Sex- and age-related differences in outcomes of patients with acute myocardial infarction: MINOCA vs MIOCA. Eur Heart J Acute Cardiovasc Care. 2023;12(9):604–14. https://doi.org/10.1093/ehjacc/zuad059.CrossRefPubMed

36.

•• Gulati M, Cooper-DeHoff RM, McClure C, Johnson BD, Shaw LJ, Handberg EM, et al. Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women’s Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project. Arch Intern Med. 2009;169(9):843–850. https://doi.org/10.1001/archinternmed.2009.50. Significant as the most extensive series demonstrating the adverse prognosis of ischemia with non-obstructive coronary artery disease (INOCA) in women compared to a control group of healthy females.CrossRefPubMedPubMedCentral

37.

Spadafora L, Mohammadi T, Bernardi M, Testa A, Tun HN, D'Ascenzo F et al. Appraising features and outlook of women and men discharged after an acute coronary syndrome: evidence from the 23,700-patient PRAISE International Registry. Panminerva Med. 2023; 65(4):454-60. https://doi.org/10.23736/S0031-0808.23.04909-1

38.

Reunanen A, Suhonen O, Aromaa A, Knekt P, Pyorala K. Incidence of different manifestations of coronary heart disease in middle-aged Finnish men and women. Acta Med Scand. 1985;218(1):19–26. https://doi.org/10.1111/j.0954-6820.1985.tb08819.x.CrossRefPubMed

39.

Lerner DJ, Kannel WB. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J. 1986;111(2):383–90. https://doi.org/10.1016/0002-8703(86)90155-9.CrossRefPubMed

40.

Kannel WB, Feinleib M. Natural history of angina pectoris in the Framingham study Prognosis and survival. Am J Cardiol. 1972;29(2):154–63. https://doi.org/10.1016/0002-9149(72)90624-8.CrossRefPubMed

41.

Ford ES, Giles WH, Croft JB. Prevalence of nonfatal coronary heart disease among American adults. Am Heart J. 2000;139(3):371–7. https://doi.org/10.1016/S0002-8703(00)90076-0.CrossRefPubMed

42.

Smith WC, Kenicer MB, Tunstall-Pedoe H, Clark EC, Crombie IK. Prevalence of coronary heart disease in Scotland: Scottish Heart Health Study. Br Heart J. 1990;64(5):295–8. https://doi.org/10.1136/hrt.64.5.295.CrossRefPubMedPubMedCentral

43.

Cosin J, Asin E, Marrugat J, Elosua R, Aros F, de los Reyes M, et al. Prevalence of angina pectoris in Spain. PANES Study group. Eur J Epidemiol. 1999;15(4):323–30. https://doi.org/10.1023/a:1007542700074.CrossRefPubMed

44.

Hemingway H, Langenberg C, Damant J, Frost C, Pyorala K, Barrett-Connor E. Prevalence of angina in women versus men: a systematic review and meta-analysis of international variations across 31 countries. Circulation. 2008;117(12):1526–36. https://doi.org/10.1161/CIRCULATIONAHA.107.720953.CrossRefPubMed

45.

Beatty AL, Spertus JA, Whooley MA. Frequency of angina pectoris and secondary events in patients with stable coronary heart disease (from the Heart and Soul Study). Am J Cardiol. 2014;114(7):997–1002. https://doi.org/10.1016/j.amjcard.2014.07.009.CrossRefPubMedPubMedCentral

46.

Eisen A, Bhatt DL, Steg PG, Eagle KA, Goto S, Guo J, et al. Angina and Future Cardiovascular Events in Stable Patients With Coronary Artery Disease: Insights From the Reduction of Atherothrombosis for Continued Health (REACH) Registry. J Am Heart Assoc. 2016;5(10). https://doi.org/10.1161/JAHA.116.004080.

47.

Gerber Y, Weston SA, Berardi C, McNallan SM, Jiang R, Redfield MM, Roger VL. Contemporary trends in heart failure with reduced and preserved ejection fraction after myocardial infarction: a community study. Am J Epidemiol. 2013;178(8):1272–80. https://doi.org/10.1093/aje/kwt109.CrossRefPubMedPubMedCentral

48.

Hellermann JP, Jacobsen SJ, Gersh BJ, Rodeheffer RJ, Reeder GS, Roger VL. Heart failure after myocardial infarction: a review. Am J Med. 2002;113(4):324–30. https://doi.org/10.1016/s0002-9343(02)01185-3.CrossRefPubMed

49.

Jenca D, Melenovsky V, Stehlik J, Stanek V, Kettner J, Kautzner J, et al. Heart failure after myocardial infarction: incidence and predictors. ESC Heart Fail. 2021;8(1):222–37. https://doi.org/10.1002/ehf2.13144.CrossRefPubMed

50.

Lewis EF, Velazquez EJ, Solomon SD, Hellkamp AS, McMurray JJ, Mathias J, et al. Predictors of the first heart failure hospitalization in patients who are stable survivors of myocardial infarction complicated by pulmonary congestion and/or left ventricular dysfunction: a VALIANT study. Eur Heart J. 2008;29(6):748–56. https://doi.org/10.1093/eurheartj/ehn062.CrossRefPubMed

51.

Gho J, Postema PG, Conijn M, Bruinsma N, de Jong J, Bezzina CR, et al. Heart failure following STEMI: a contemporary cohort study of incidence and prognostic factors. Open Heart. 2017;4(2):e000551. https://doi.org/10.1136/openhrt-2016-000551.CrossRefPubMedPubMedCentral

52.

Shih JY, Chen ZC, Chang HY, Liu YW, Ho CH, Chang WT. Risks of age and sex on clinical outcomes post myocardial infarction. Int J Cardiol Heart Vasc. 2019;23:100350. https://doi.org/10.1016/j.ijcha.2019.100350.CrossRefPubMedPubMedCentral

53.

Bucholz EM, Butala NM, Rathore SS, Dreyer RP, Lansky AJ, Krumholz HM. Sex differences in long-term mortality after myocardial infarction: a systematic review. Circulation. 2014;130(9):757–67. https://doi.org/10.1161/CIRCULATIONAHA.114.009480.CrossRefPubMedPubMedCentral

54.

Wellings J, Kostis JB, Sargsyan D, Cabrera J, Kostis WJ, Myocardial Infarction Data Acquisition System Study G. Risk Factors and Trends in Incidence of Heart Failure Following Acute Myocardial Infarction. Am J Cardiol. 2018;122(1):1–5. https://doi.org/10.1016/j.amjcard.2018.03.005.CrossRefPubMed

55.

Kelly DJ, Gershlick T, Witzenbichler B, Guagliumi G, Fahy M, Dangas G, et al. Incidence and predictors of heart failure following percutaneous coronary intervention in ST-segment elevation myocardial infarction: the HORIZONS-AMI trial. Am Heart J. 2011;162(4):663–70. https://doi.org/10.1016/j.ahj.2011.08.002.CrossRefPubMed

56.

Pasupathy S, Air T, Dreyer RP, Tavella R, Beltrame JF. Systematic review of patients presenting with suspected myocardial infarction and nonobstructive coronary arteries. Circulation. 2015;131(10):861–70. https://doi.org/10.1161/CIRCULATIONAHA.114.011201.CrossRefPubMed

57.

Kong M, Pei Z, Xie Y, Gao Y, Li J, He G. Prognostic factors of MINOCA and their possible mechanisms. Prev Med Rep. 2024;39:102643. https://doi.org/10.1016/j.pmedr.2024.102643.CrossRefPubMedPubMedCentral

58.

Armillotta M, Amicone S, Bergamaschi L, Angeli F, Rinaldi A, Paolisso P, et al. Predictive value of Killip classification in MINOCA patients. Eur J Intern Med. 2023. https://doi.org/10.1016/j.ejim.2023.08.011

59.

Tamis-Holland JE, Jneid H, Reynolds HR, Agewall S, Brilakis ES, Brown TM, et al. Contemporary Diagnosis and Management of Patients With Myocardial Infarction in the Absence of Obstructive Coronary Artery Disease: A Scientific Statement From the American Heart Association. Circulation. 2019;139(18):e891–908. https://doi.org/10.1161/CIR.0000000000000670.CrossRefPubMed

60.

Collet JP, Thiele H, Barbato E, Barthelemy O, Bauersachs J, Bhatt DL, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2021;42(14):1289–367. https://doi.org/10.1093/eurheartj/ehaa575.CrossRefPubMed

61.

Williams MGL, Dastidar A, Liang K, Johnson TW, Baritussio A, Strange J, et al. Sex differences in patients with acute coronary syndromes and non-obstructive coronary arteries: Presentation and outcome. Int J Cardiol. 2022;372:15–22. https://doi.org/10.1016/j.ijcard.2022.11.032.CrossRefPubMed

62.

Chaudhary R, Bashline M, Novelli EM, Bliden KP, Tantry US, Olafiranye O, et al. Sex-related differences in clinical outcomes among patients with myocardial infarction with nonobstructive coronary artery disease: A systematic review and meta-analysis. Int J Cardiol. 2022;369:1–4. https://doi.org/10.1016/j.ijcard.2022.07.050.CrossRefPubMed

63.

Rahman H, Demir OM, Khan F, Ryan M, Ellis H, Mills MT, et al. Physiological Stratification of Patients With Angina Due to Coronary Microvascular Dysfunction. J Am Coll Cardiol. 2020;75(20):2538–49. https://doi.org/10.1016/j.jacc.2020.03.051.CrossRefPubMedPubMedCentral

64.

Samuels Bruce A, Shah Samit M, Widmer RJ, Kobayashi Y, Miner Steven ES, Taqueti Viviany R, et al. Comprehensive Management of ANOCA, Part 1—Definition, Patient Population, and Diagnosis. J Am Coll Cardiol. 2023;82(12):1245–63. https://doi.org/10.1016/j.jacc.2023.06.043.CrossRefPubMed

65.

Smilowitz Nathaniel R, Prasad M, Widmer RJ, Toleva O, Quesada O, Sutton Nadia R, et al. Comprehensive Management of ANOCA, Part 2—Program Development, Treatment, and Research Initiatives. J Am Coll Cardiol. 2023;82(12):1264–79. https://doi.org/10.1016/j.jacc.2023.06.044.CrossRefPubMed

66.

Shaw LJ, Bugiardini R, Merz CN. Women and ischemic heart disease: evolving knowledge. J Am Coll Cardiol. 2009;54(17):1561–75. https://doi.org/10.1016/j.jacc.2009.04.098.CrossRefPubMedPubMedCentral

67.

Jespersen L, Hvelplund A, Abildstrøm SZ, Pedersen F, Galatius S, Madsen JK, et al. Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events. Eur Heart J. 2012;33(6):734–44. https://doi.org/10.1093/eurheartj/ehr331.CrossRefPubMed

68.

Kobayashi Y, Fearon WF, Honda Y, Tanaka S, Pargaonkar V, Fitzgerald PJ, et al. Effect of Sex Differences on Invasive Measures of Coronary Microvascular Dysfunction in Patients With Angina in the Absence of Obstructive Coronary Artery Disease. JACC Cardiovasc Interv. 2015;8(11):1433–41. https://doi.org/10.1016/j.jcin.2015.03.045.CrossRefPubMedPubMedCentral

69.

Campbell P, Rutten FH, Lee MM, Hawkins NM, Petrie MC. Heart failure with preserved ejection fraction: everything the clinician needs to know. Lancet. 2024;493(19431):1983–2. https://doi.org/10.1016/S0140-6736(23)02756-3.CrossRef

70.

Azuma M, Kato S, Fukui K, Horita N, Utsunomiya D. Microvascular dysfunction in patients with heart failure with preserved ejection fraction: A meta-analysis. Microcirculation. 2023;30(7):e12822. https://doi.org/10.1111/micc.12822.CrossRefPubMed

71.

Lin X, Wu G, Wang S, Huang J. The prevalence of coronary microvascular dysfunction (CMD) in heart failure with preserved ejection fraction (HFpEF): a systematic review and meta-analysis. Heart Fail Rev. 2024;29(2):405–16. https://doi.org/10.1007/s10741-023-10362-x.CrossRefPubMed

72.

Taqueti VR, Solomon SD, Shah AM, Desai AS, Groarke JD, Osborne MT, et al. Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction. Eur Heart J. 2018;39(10):840–9. https://doi.org/10.1093/eurheartj/ehx721.CrossRefPubMed

73.

Sedlak TL, Lee M, Izadnegahdar M, Merz CN, Gao M, Humphries KH. Sex differences in clinical outcomes in patients with stable angina and no obstructive coronary artery disease. Am Heart J. 2013;166(1):38–44. https://doi.org/10.1016/j.ahj.2013.03.015.CrossRefPubMed

74.

Jones E, Wei J, Nelson MD, Bakir M, Mehta PK, Shufelt C, et al. N-Terminal pro-B-type natriuretic peptide and coronary microvascular dysfunction in women with preserved ejection fraction: A report from the Women’s Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD) study. PLoS One. 2020;15(12):e0243213. https://doi.org/10.1371/journal.pone.0243213.CrossRefPubMedPubMedCentral

75.

Hartiala JA, Tang WH, Wang Z, Crow AL, Stewart AF, Roberts R, et al. Genome-wide association study and targeted metabolomics identifies sex-specific association of CPS1 with coronary artery disease. Nat Commun. 2016;7:10558. https://doi.org/10.1038/ncomms10558.CrossRefPubMedPubMedCentral

76.

Dungan JR, Qin X, Gregory SG, Cooper-Dehoff R, Duarte JD, Qin H, et al. Sex-dimorphic gene effects on survival outcomes in people with coronary artery disease. Am Heart J Plus. 2022;17. https://doi.org/10.1016/j.ahjo.2022.100152.

77.

Dungan JR, Qin X, Hurdle M, Haynes CS, Hauser ER, Kraus WE. Genome-Wide Variants Associated With Longitudinal Survival Outcomes Among Individuals With Coronary Artery Disease. Front Genet. 2021;12:661497. https://doi.org/10.3389/fgene.2021.661497.CrossRefPubMedPubMedCentral

78.

Pepine CJ, Kerensky RA, Lambert CR, Smith KM, von Mering GO, Sopko G, Bairey Merz CN. Some thoughts on the vasculopathy of women with ischemic heart disease. J Am Coll Cardiol. 2006;47(3 Suppl):S30-5. https://doi.org/10.1016/j.jacc.2005.09.023.CrossRefPubMed

79.

Puymirat E, Simon T, Steg PG, Schiele F, Gueret P, Blanchard D, et al. Association of changes in clinical characteristics and management with improvement in survival among patients with ST-elevation myocardial infarction. JAMA. 2012;308(10):998–1006. https://doi.org/10.1001/2012.jama.11348.CrossRefPubMed

80.

Huxley RR, Peters SA, Mishra GD, Woodward M. Risk of all-cause mortality and vascular events in women versus men with type 1 diabetes: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2015;3(3):198–206. https://doi.org/10.1016/S2213-8587(14)70248-7.CrossRefPubMed

81.

Shah AJ, Ghasemzadeh N, Zaragoza-Macias E, Patel R, Eapen DJ, Neeland IJ, et al. Sex and age differences in the association of depression with obstructive coronary artery disease and adverse cardiovascular events. J Am Heart Assoc. 2014;3(3):e000741. https://doi.org/10.1161/JAHA.113.000741.CrossRefPubMedPubMedCentral

82.

Leboube S, Camboulives L, Bochaton T, Amaz C, Bergerot C, Altman M, et al. What underlies sex differences in heart failure onset within the first year after a first myocardial infarction? Front Cardiovasc Med. 2023;10:1290375. https://doi.org/10.3389/fcvm.2023.1290375.CrossRefPubMed

83.

De Luca G, Suryapranata H, Ottervanger JP, Antman EM. Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts. Circulation. 2004;109(10):1223–5. https://doi.org/10.1161/01.CIR.0000121424.76486.20.CrossRefPubMed

84.

O’Connor CT, Ibrahim A, Buckley A, Maguire C, Kumar R, Kumar J, et al. Total ischaemic time in STEMI: factors influencing systemic delay. Br J Cardiol. 2022;29(2):17. https://doi.org/10.5837/bjc.2022.017.CrossRefPubMedPubMedCentral

85.

Zhou S, Zhang Y, Dong X, Zhang X, Ma J, Li N, et al. Sex Disparities in Management and Outcomes Among Patients With Acute Coronary Syndrome. JAMA Netw Open. 2023;6(10):e2338707. https://doi.org/10.1001/jamanetworkopen.2023.38707.CrossRefPubMedPubMedCentral

86.

Schulte KJ, Mayrovitz HN. Myocardial Infarction Signs and Symptoms: Females vs. Males Cureus. 2023;15(4):e37522. https://doi.org/10.7759/cureus.37522.CrossRefPubMed

87.

Erbel R, Ge J, Bockisch A, Kearney P, Gorge G, Haude M, et al. Value of intracoronary ultrasound and Doppler in the differentiation of angiographically normal coronary arteries: a prospective study in patients with angina pectoris. Eur Heart J. 1996;17(6):880–9. https://doi.org/10.1093/oxfordjournals.eurheartj.a014969.CrossRefPubMed

88.

Kang SJ, Ahn JM, Han S, Lee JY, Kim WJ, Park DW, et al. Sex differences in the visual-functional mismatch between coronary angiography or intravascular ultrasound versus fractional flow reserve. JACC Cardiovasc Interv. 2013;6(6):562–8. https://doi.org/10.1016/j.jcin.2013.02.016.CrossRefPubMed

89.

Johnston N, Schenck-Gustafsson K, Lagerqvist B. Are we using cardiovascular medications and coronary angiography appropriately in men and women with chest pain? Eur Heart J. 2011;32(11):1331–6. https://doi.org/10.1093/eurheartj/ehr009.CrossRefPubMed

90.

Han SH, Bae JH, Holmes DR Jr, Lennon RJ, Eeckhout E, Barsness GW, et al. Sex differences in atheroma burden and endothelial function in patients with early coronary atherosclerosis. Eur Heart J. 2008;29(11):1359–69. https://doi.org/10.1093/eurheartj/ehn142.CrossRefPubMed

91.

Michel TC, Abhiram P, Rajiv G, Lilach OL, Amir L. Sex-specific differences in coronary blood flow and flow velocity reserve in symptomatic patients with non-obstructive disease. EuroIntervention. 2021;16(13):1079–84.CrossRef

92.

Elesber AA, Redfield MM, Rihal CS, Prasad A, Lavi S, Lennon R, et al. Coronary endothelial dysfunction and hyperlipidemia are independently associated with diastolic dysfunction in humans. Am Heart J. 2007;153(6):1081–7. https://doi.org/10.1016/j.ahj.2007.03.007.CrossRefPubMed

93.

Shah SJ, Lam CSP, Svedlund S, Saraste A, Hage C, Tan RS, et al. Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: PROMIS-HFpEF. Eur Heart J. 2018;39(37):3439–50. https://doi.org/10.1093/eurheartj/ehy531.CrossRefPubMedPubMedCentral

94.

Cornuault L, Rouault P, Duplaa C, Couffinhal T, Renault MA. Endothelial Dysfunction in Heart Failure With Preserved Ejection Fraction: What are the Experimental Proofs? Front Physiol. 2022;13:906272. https://doi.org/10.3389/fphys.2022.906272.CrossRefPubMedPubMedCentral

95.

Canto ED, van Deursen L, Hoek AG, Elders PJM, den Ruijter HM, van der Velden J, et al. Microvascular endothelial dysfunction in skin is associated with higher risk of heart failure with preserved ejection fraction in women with type 2 diabetes: the Hoorn Diabetes Care System Cohort. Cardiovasc Diabetol. 2023;22(1):234. https://doi.org/10.1186/s12933-023-01935-z.CrossRefPubMedPubMedCentral

96.

Morgan H, Sinha A, McEntegart M, Hardman SM, Perera D. Evaluation of the causes of sex disparity in heart failure trials. Heart. 2022;108(19):1547–52. https://doi.org/10.1136/heartjnl-2021-320696.CrossRefPubMed

97.

Ekpo E, Balla S, Ngo S, Witting C, Sarraju A, Furst A, Rodriguez F. Underrepresentation of Women in Reduced Ejection Heart Failure Clinical Trials with Improved Mortality or Hospitalization. JACC: Advances 2023. https://doi.org/10.1016/j.jacadv.2023.100743

98.

Ghare MI, Chandrasekhar J, Mehran R, Ng V, Grines C, Lansky A. Sex Disparities in Cardiovascular Device Evaluations: Strategies for Recruitment and Retention of Female Patients in Clinical Device Trials. JACC Cardiovasc Interv. 2019;12(3):301–8. https://doi.org/10.1016/j.jcin.2018.10.048.CrossRefPubMed

99.

Haider A, Bengs S, Luu J, Osto E, Siller-Matula JM, Muka T, Gebhard C. Sex and gender in cardiovascular medicine: presentation and outcomes of acute coronary syndrome. Eur Heart J. 2020;41(13):1328–36. https://doi.org/10.1093/eurheartj/ehz898.CrossRefPubMed

Titel: Impact of Sex in the Incidence of Heart Failure in Patients with Chronic Coronary Syndrome
verfasst von: Ramón López-Palop
Pilar Carrillo
Íñigo Lozano
Publikationsdatum: 04.05.2024
Verlag: Springer US
Erschienen in: Current Heart Failure Reports
Print ISSN: 1546-9530
Elektronische ISSN: 1546-9549
DOI: https://doi.org/10.1007/s11897-024-00663-z

Neu im Fachgebiet Kardiologie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Impact of Sex in the Incidence of Heart Failure in Patients with Chronic Coronary Syndrome

Abstract

Purpose of Review

Recent Findings

Summary

Neu im Fachgebiet Kardiologie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

Update Kardiologie

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Purpose of Review

Recent Findings

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Neu im Fachgebiet Kardiologie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

Update Kardiologie